Screener
Oric Pharmaceuticals, Inc. ORIC Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Oric Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.
The source filing: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-204047
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Proceeds from issuance of common stock | 60,881 | — |
| Issuance costs associated with financings | (993) | — |
| Payment of deferred issuance costs | — | (242) |
| Proceeds from stock option exercises | 1,252 | 253 |
| Net cash provided by financing activities | 61,140 | 11 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 10,727 | (10,072) |
| Cash, cash equivalents and restricted cash at beginning of period | 46,160 | 59,897 |
| Cash, cash equivalents and restricted cash at end of period | $56,887 | $49,825 |
Item 1. Financial Statements.
FAQ
- What is Oric Pharmaceuticals, Inc.'s net change in cash?
- Oric Pharmaceuticals, Inc. (ORIC) reported net change in cash of $10.73M in Q1 2026.
- How has Oric Pharmaceuticals, Inc.'s net change in cash changed year-over-year?
- Oric Pharmaceuticals, Inc.'s net change in cash increased by 206.5% year-over-year, from -$10.07M to $10.73M.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.
Ask your AI about Oric Pharmaceuticals, Inc.'s net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude